Company Profiles

driven by the PitchBook Platform

Adjuvance

Description

Operator of a bio-pharmaceutical company designed to offer vaccines. The company's SAPONEX products are critical components that are added to many vaccines, enabling people to improve their immunity system.

PRIVATE

Status

Seed

Latest Deal Type

$2.72M

Latest Deal Amount

$2.72M

Total Amount Raised

2

Investors

Description

Operator of a bio-pharmaceutical company designed to offer vaccines. The company's SAPONEX products are critical components that are added to many vaccines, enabling people to improve their immunity system.

Website:

www.adjuvancetechnologies.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Pharmaceuticals

Primary Office

116 West 22nd Street 6th Floor New York, NY 10010United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Adjuvance's full profile, request a free trial.

Adjuvance Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Adjuvance Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Invest NebraskaVenture CapitalMinority000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Invest Nebraska Venture Capital
U.S. Department of Health and Human Services Government

Adjuvance Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Tyler MartinChairman & Chief Executive Officer
Jeffrey GardnerCo-Founder, Board Member & Chief Business Officer
Govind RagupathiCo-Founder
Philip Livingston MDCo-Founder, Board Member and Chief Scientific Officer
Christopher Frigon JDBoard Member and Corporate Secretary
Tyler Martin Chairman & Chief Executive Officer
Jeffrey Gardner Co-Founder, Board Member & Chief Business Officer
Govind Ragupathi Co-Founder
Philip Livingston MD Co-Founder, Board Member and Chief Scientific Officer
Christopher Frigon JD Board Member and Corporate Secretary

Adjuvance Board Members (5)

NameRepresentingRoleSinceContact
Info
Christopher Frigon JDSelfBoard Member and Corporate Secretary000 0000
Gregory PolandAdjuvanceVice Chairman & Advisor000 0000
John GalloAdjuvanceBoard Member000 0000
Mary GinAdjuvanceBoard Member000 0000
Tyler MartinAdjuvanceChairman & Chief Executive Officer000 0000
Christopher Frigon JD Board Member and Corporate Secretary Self
Gregory Poland Vice Chairman & Advisor Adjuvance
John Gallo Board Member Adjuvance
Mary Gin Board Member Adjuvance
Tyler Martin Chairman & Chief Executive Officer Adjuvance
Request full access to PitchBook